FCM
GILD icon

Frontier Capital Management’s Gilead Sciences GILD Stock Holding History

Frontier Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-33,746
Closed -$3.59M – 361
2014
Q3 		$3.59M Buy
33,746
+390
+1% +$38.2K 0.03% 293
2014
Q2 		$2.77M Sell
33,356
-4,175
-11% -$325K 0.02% 300
2014
Q1 		$2.66M Buy
37,531
+1,241
+3% +$97.3K 0.02% 312
2013
Q4 		$2.73M Sell
36,290
-38,490
-51% -$2.68M 0.02% 301
2013
Q3 		$4.7M Sell
74,780
-7,400
-9% -$442K 0.04% 288
2013
Q2 		$4.21M Buy
+82,180
New +$4.28M 0.04% 300

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Frontier Capital Management's GILD Position: Q4 2014 in Review

Frontier Capital Management sold out of Gilead Sciences (GILD) in Q4 2014, closing a stake of 33,746 shares — an estimated $3.59M sold.

Frontier Capital Management first reported a position in GILD in Q2 2013 and held it in 6 quarters. The position peaked at $4.7M in Q3 2013. 1,438 funds tracked by Wall St. Rank hold GILD as of Q4 2014.

  • Frontier Capital Management reported no remaining Gilead Sciences position as of Q4 2014 after selling out during the quarter.
  • Frontier Capital Management sold 33,746 Gilead Sciences shares in Q4 2014, an estimated $3.59M.
  • Frontier Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 6 quarters.
  • Frontier Capital Management's Gilead Sciences position peaked at $4.7M in Q3 2013.
  • 1,438 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2014.

Based on Frontier Capital Management's 13F filing for Q4 2014, filed 23 Jan 2015.